Aclarion, Inc. Files Material Definitive Agreement 8-K
Ticker: ACONW · Form: 8-K · Filed: Jun 26, 2024 · CIK: 1635077
| Field | Detail |
|---|---|
| Company | Aclarion, INC. (ACONW) |
| Form Type | 8-K |
| Filed Date | Jun 26, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-definitive-agreement, corporate-filing
Related Tickers: ACON
TL;DR
Aclarion (ACON) filed an 8-K for a material definitive agreement - new deal incoming.
AI Summary
On June 26, 2024, Aclarion, Inc. filed an 8-K report detailing a material definitive agreement. The company, formerly known as Nocimed, Inc., is incorporated in Delaware and operates in the medical laboratories sector.
Why It Matters
This filing indicates a significant new contract or partnership for Aclarion, Inc., which could impact its future business operations and financial performance.
Risk Assessment
Risk Level: medium — Material definitive agreements can introduce new risks or opportunities, the specifics of which are not yet fully disclosed in this initial filing.
Key Numbers
- 001-41358 — SEC File Number (Identifies Aclarion's filing with the SEC)
- 47-3324725 — IRS Employer Identification No. (Company's tax identification number)
Key Players & Entities
- Aclarion, Inc. (company) — Registrant
- Nocimed, Inc. (company) — Former company name
- June 26, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 80021 (zip_code) — Business address zip code
FAQ
What is the nature of the material definitive agreement filed by Aclarion, Inc.?
The 8-K filing indicates the entry into a material definitive agreement, but the specific details of the agreement are not provided in this summary.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on June 26, 2024.
What was Aclarion, Inc.'s former name?
Aclarion, Inc. was formerly known as Nocimed, Inc.
In which state is Aclarion, Inc. incorporated?
Aclarion, Inc. is incorporated in Delaware.
What is Aclarion, Inc.'s business address?
Aclarion, Inc.'s business address is 8181 Arista Place, Suite 100, Broomfield, Colorado 80021.
Filing Stats: 450 words · 2 min read · ~2 pages · Grade level 10.8 · Accepted 2024-06-26 08:30:10
Filing Documents
- acon_8k-pr.htm (8-K) — 31KB
- acon_ex9901.htm (EX-99.1) — 13KB
- 0001683168-24-004470.txt ( ) — 262KB
- acon-20240626.xsd (EX-101.SCH) — 4KB
- acon-20240626_def.xml (EX-101.DEF) — 26KB
- acon-20240626_lab.xml (EX-101.LAB) — 36KB
- acon-20240626_pre.xml (EX-101.PRE) — 25KB
- acon_8k-pr_htm.xml (XML) — 6KB
01 Entry into
Item 1.01 Entry into a Material Definitive Agreement. On June 26, 2024, Aclarion, Inc. (the "Company") issued a press release announcing an initial payer coverage of the Company's Nociscan product by AXA, a private medical insurance provider in the U.K., for the greater London, U.K. area. A copy of the press release is attached hereto as Exhibit 99.1.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 Press Release dated June 26, 2024 104 Cover Page Interactive Data File - the cover page iXBRL tags are embedded within the Inline XBRL document 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ACLARION, INC. June 26, 2024 /s/ John Lorbiecki Name: John Lorbiecki Title: Chief Financial Officer 3